Concord Biotech Limited (NSE:CONCORDBIO)
India
· Delayed Price · Currency is INR 1,134.50
+62.50 (5.83%)
Apr 29, 2026, 3:30 PM IST
Concord Biotech Revenue
Concord Biotech had revenue of 2.78B INR in the quarter ending December 31, 2025, with 13.74% growth. This brings the company's revenue in the last twelve months to 11.59B, up 6.38% year-over-year. In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B with 18.01% growth.
Revenue (ttm)
11.59B
Revenue Growth
+6.38%
P/S Ratio
9.68
Revenue / Employee
7.38M
Employees
1,571
Market Cap
112.15B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Blue Jet Healthcare | 10.53B |
| OneSource Specialty Pharma | 14.19B |
| Supriya Lifescience | 7.35B |
| Zota Health Care | 4.73B |
| Anthem Biosciences | 20.02B |
| Dishman Carbogen Amcis | 27.97B |
| Panacea Biotec | 6.06B |
| Biocon | 168.27B |
Concord Biotech News
- 2 months ago - Concord Biotech Transcript: Q3 25/26 - Transcripts
- 5 months ago - Concord Biotech Transcript: Q2 25/26 - Transcripts
- 9 months ago - Concord Biotech Transcript: Q1 25/26 - Transcripts
- 11 months ago - Concord Biotech Transcript: Q4 24/25 - Transcripts
- 1 year ago - Concord Biotech Transcript: Q3 24/25 - Transcripts
- 1 year ago - Concord Biotech Transcript: Q2 24/25 - Transcripts
- 1 year ago - Concord Biotech Transcript: Q1 24/25 - Transcripts